Get the Daily Brief
Latest Biotech News
Psychedelic Drug Shows Promise, Spurs Biotech Merger Plans
Mid-stage trial data from Beckley Psytech’s intranasal psychedelic compound BPL-003 demonstrated significant symptom reduction in treatment-resistant depression, outperforming a low-dose...
New AI Advances Precision Oncology and Drug Discovery
Innovations in artificial intelligence are driving breakthroughs in cancer diagnostics, drug discovery, and clinical trial optimization. Imagene AI secured $23 million in Series B funding to...
Moderna’s mRNA Flu Vaccine Outperforms Licensed Comparator, FDA Talks Loom
Moderna announced positive Phase 3 results for its mRNA-1010 seasonal influenza vaccine, demonstrating a 26.6% relative vaccine efficacy over a standard-dose marketed influenza shot in adults aged...
New Insights into Chemotherapy’s Genetic Impact on Healthy Blood Cells
A comprehensive study led by the Wellcome Sanger Institute and University of Cambridge systematically examined the somatic genetic effects of chemotherapy on normal blood cells. Using whole-genome...
Breakthrough in Targeting Hard-to-Treat Breast Cancers
Researchers have highlighted the role of circular RNA circLIMK1-005 in promoting lung adenocarcinoma progression via interaction with the RPA1-CDK4 pathway, offering a promising molecular target....
Gut Microbiota and Metabolites Linked to Neurological Disorders
Groundbreaking studies have unveiled novel connections between the gut microbiome and neurological diseases. One investigation reveals that alterations in gut-derived metabolites are associated...
Biotech Venture Funding and Market Movements Shape Industry Landscape
Catalio Capital Management has closed its $400 million Nexus Fund IV to invest in novel healthcare innovations amid a challenging buyer’s market in biotech. The fund supports new company launches...
Precision Medicine Advances with Machine Learning and Genomics Integration
Significant progress is being made in leveraging machine learning and genomic data to improve disease prediction and treatment personalization. Novel algorithms predict breast cancer incidence...
Regulatory and Industry Movements in Healthcare and Biotech
Recent regulatory actions and industry developments include the FDA maintaining a broad definition of cybersecurity devices in its latest guidance and Hong Kong establishing the Centre for Medical...
Psychedelic drug phase 2 success spurs Atai and Beckley merger plans
Atai Life Sciences and Beckley Psytech revealed positive Phase 2b results for intranasal mebufotenin in treatment-resistant depression, significantly reducing symptoms compared to low-dose...
AbbVie to acquire Capstan Therapeutics for $2.1 billion, boosting in vivo CAR-T pipeline
AbbVie secured a $2.1 billion acquisition of Capstan Therapeutics, gaining access to its early-phase in vivo CAR-T platform targeting autoimmune and cancer indications. The purchase follows...
Moderna’s mRNA flu vaccine beats approved comparator, sets up FDA submission
Moderna announced that its mRNA-based seasonal influenza vaccine, mRNA-1010, demonstrated a 26.6% relative vaccine efficacy over a licensed standard-dose flu vaccine in adults aged 50 and older...
CRISPR technology advances with web tools and new activation methods
Recent developments in CRISPR genome editing include novel web-based tools that improve off-target prediction by integrating individual genetic variations, enhancing precision in gene editing...
Pharmacogenomics trial in Scotland tests utility across 60 medications
A pharmacogenomics trial initiated in Scotland is recruiting up to 4,000 patients to evaluate the clinical utility of preemptive genetic testing across 60 medications. The study, conducted in...
AI and digital pathology collaborations expand precision medicine capabilities
Imagene AI closed a $23 million Series B financing round led by Oracle CTO Larry Ellison to advance multi-modal digital pathology foundation models that integrate histopathology, molecular...
Gut microbiota bioaccumulate toxic PFAS chemicals impacting human health
Groundbreaking research demonstrates that human gut bacteria can bioaccumulate per- and polyfluoroalkyl substances (PFAS), known as 'forever chemicals,' posing environmental and health concerns....
Clinical innovations in cancer and immunotherapy trials progress
Multiple clinical updates reflect ongoing advances in oncology, including Blacksmith Medicines securing a patent for antibacterial compounds targeting LpxC, Hemispherian receiving orphan drug...
Investment and M&A activity highlight biopharma market dynamics
Recent financial developments include Concentra Biosciences acquiring struggling biotech IGM Biosciences as part of an ongoing buyout streak and Innovent Biologics raising HKD 4.3 billion ($547...
U.S. Uterine Cancer Burden Set to Surge with Racial Disparities
Recent comprehensive studies led by Columbia University and published in major journals forecast a significant rise in uterine cancer incidence and mortality in the United States over the next 25...
Concentra Biosciences Accelerates M&A with Latest IGM Buyout
Concentra Biosciences, under hedge fund Tang Capital, has continued its aggressive acquisition strategy, picking up struggling biotech IGM Biosciences for $1.25 per share. This marks Concentra's...